GLP-1 Dosing & Titration Guide

Proper dose titration is the single most important factor in tolerating GLP-1 medications successfully. The most common reason people quit these drugs is side effects that could have been avoided — or at least minimized — with a proper ramp-up schedule and practical management strategies.

Both semaglutide and tirzepatide follow a graduated dosing approach: you start at a low dose that is sub-therapeutic for weight loss but allows your body to adapt, then increase monthly until you reach an effective maintenance dose. Rushing this process — or skipping steps — leads to the severe nausea and GI distress that gives these medications a bad reputation in some circles.

This guide covers the official titration schedules for all major GLP-1 medications, practical tips for each dose step, and strategies for the common side effects you may encounter. For an overview of what GLP-1 is, see our beginner's guide to GLP-1. To understand the biological mechanisms behind why titration matters, read how GLP-1 peptides work.

Semaglutide Dosing Schedule (Ozempic & Wegovy)

Semaglutide is available in two branded formulations: Ozempic (approved for type 2 diabetes, max 2.0mg) and Wegovy (approved for obesity, max 2.4mg). The titration approach is the same — gradual monthly increases.

Wegovy Titration Schedule

Ozempic follows the same initial steps but maxes out at 2.0mg/week. The 0.25mg and 0.5mg steps are identical. For diabetes management, many patients are maintained at 0.5mg or 1.0mg. The weight loss effect is dose-dependent — higher doses produce more weight loss but also more side effects. For a detailed comparison of semaglutide to tirzepatide, see our head-to-head comparison.

Tirzepatide Dosing Schedule (Mounjaro & Zepbound)

Tirzepatide has more dose steps than semaglutide, allowing for more granular titration. This can be advantageous for patients who are sensitive to dose increases.

Zepbound / Mounjaro Titration Schedule

Many physicians will keep patients at 5mg or 10mg if the response is adequate. Not everyone needs 15mg. The 7.5mg and 12.5mg steps are particularly useful for patients who experience significant GI side effects with larger dose jumps.

Managing Side Effects During Dose Escalation

Each dose increase may temporarily trigger GI side effects that were absent or resolved at the previous dose. This is normal and typically resolves within 1-2 weeks as your body adapts. Here are evidence-based strategies for the most common issues:

Nausea

• Eat smaller, more frequent meals rather than large portions
• Avoid high-fat and fried foods, which exacerbate delayed gastric emptying
• Ginger tea, ginger capsules, or ginger chews can provide natural anti-nausea relief
• Stay well-hydrated — sip water throughout the day
• Consider injecting in the evening so you sleep through the initial nausea peak
• Your physician may prescribe ondansetron (Zofran) for severe nausea during titration

Constipation

• Increase water intake significantly (aim for 80-100 oz/day)
• Add fiber gradually (psyllium husk, ground flaxseed)
• Magnesium citrate (200-400mg) acts as a gentle osmotic laxative
• Daily movement and walking help stimulate gut motility

Fatigue and Low Energy

Reduced food intake means reduced caloric energy. Ensure you're eating enough — GLP-1 medications are meant to reduce appetite, not eliminate eating. Prioritize protein (to preserve muscle and maintain satiety) and complex carbohydrates. If fatigue is severe, you may be under-eating. Track calories for a few days to ensure you're consuming at least 1,200 calories (women) or 1,500 calories (men) daily. See our comprehensive side effects guide for additional management strategies.

Finding Your Optimal Maintenance Dose

The goal of titration is not necessarily to reach the maximum dose — it's to find the dose that provides adequate appetite control and weight loss with tolerable side effects. This is a collaborative decision between you and your physician.

Signs you've found your dose: Comfortable appetite suppression (you feel satisfied with moderate portions, not queasy or food-averse), steady weight loss of 1-2 lbs per week, manageable or absent GI side effects, adequate energy for daily activities and exercise, and you can maintain a reasonable protein intake.

Signs you may need a higher dose: Appetite suppression has faded significantly at the current dose, weight loss has stalled for 4+ weeks despite dietary adherence, and you're not experiencing meaningful side effects (suggesting room for escalation).

Signs the dose may be too high: Persistent nausea that doesn't resolve after 2-3 weeks, inability to eat enough to meet basic nutritional needs, severe fatigue, rapid weight loss exceeding 3-4 lbs/week consistently (increases gallstone and muscle loss risk), or any signs of pancreatitis (severe abdominal pain radiating to the back).

Some patients do well at lower doses (semaglutide 1.0mg, tirzepatide 5mg) and derive significant benefit without escalating further. Others need the full dose. Individual variation in GLP-1 receptor sensitivity, body composition, and metabolic factors all influence the optimal dose. Trust the process and your physician's guidance.

Nutrition & Lifestyle Optimization During GLP-1 Therapy

GLP-1 medications create a powerful window of opportunity — reduced appetite and cravings make it far easier to establish healthy eating patterns. What you eat during this window matters enormously for long-term outcomes.

Protein Priority

Adequate protein intake is the single most important dietary factor during GLP-1 therapy. Aim for 0.7-1.0g of protein per pound of body weight daily (or per pound of target body weight if obese). Protein preserves lean muscle mass during weight loss, maintains metabolic rate, and supports satiety. With reduced appetite, you may need to consciously prioritize protein at every meal. See our GLP-1 and muscle loss guide for a detailed discussion of this issue.

Resistance Training

Resistance training (weight lifting, bodyweight exercises) is strongly recommended during GLP-1 therapy to preserve muscle mass. Without it, approximately 25-40% of weight lost may come from lean tissue rather than fat. Even 2-3 sessions per week of moderate resistance training significantly improves body composition outcomes. Creatine supplementation (5g/day) may provide additional muscle preservation benefits during caloric deficit.

Hydration

GLP-1 medications increase the importance of adequate hydration. Reduced food intake means less water from food sources, and GI side effects (vomiting, diarrhea) can cause dehydration. Aim for at least 64-80 oz of water daily. Electrolyte supplementation (sodium, potassium, magnesium) may be helpful, especially during the early titration phase when GI side effects are most common.

Key Takeaways

• Never skip the titration schedule. Gradual dose increases over 4+ months are essential for tolerability. Rushing leads to severe GI side effects and dropout.
• You don't have to reach the maximum dose. Many patients achieve excellent results at intermediate doses (semaglutide 1.0mg, tirzepatide 5-10mg).
• Nausea is temporary. It typically peaks 1-3 days after each dose increase and resolves within 1-2 weeks. Smaller meals, hydration, and ginger help.
• Protein is non-negotiable. Aim for 0.7-1.0g/lb body weight daily to preserve muscle mass during weight loss.
• Resistance training is essential — it's the most effective intervention against GLP-1-related muscle loss.
• Work closely with your prescribing physician for all dose adjustments. Explore our GLP-1 hub for additional resources.

Related Reading

• GLP-1 Side Effects — side effects to monitor during titration
• Semaglutide vs Tirzepatide — comparing dosing approaches
• How GLP-1 Works — mechanism of action explained
• GLP-1 and Muscle Loss — preserving muscle during GLP-1 therapy

Frequently Asked Questions